Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CellScale is a private Canadian life science tools company that develops and sells mechanical testing systems, bioreactors, and custom instrumentation for biomaterials, mechanobiology, tissue engineering, and related biomedical research. Founded in 2005 from research at the University of Waterloo, the company commercializes instruments used to characterize the mechanical properties of natural tissues, hydrogels, engineered microtissues, 3D bioprinted constructs, and orthopedic or soft biomaterials. Its product portfolio includes uniaxial, biaxial, and micro-scale testing systems as well as cell and tissue stimulation platforms. CellScale primarily serves academic, translational, and industrial R&D customers rather than operating a therapeutic drug pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CellScale Biomaterials.